Hi — thank you for your thoughtful and honest question. You’re not alone in hoping for a gentler, less-invasive alternative to implants or fat transfer. I completely understand wanting a little more upper-pole fullness without the risks or downtime of surgery. I want to walk you through what I know — what these injections might offer, and what they cannot reliably do, so you can make an informed decision. ✅ What Renuva / Lanluma are (in theory) Renuva is a processed “adipose matrix” derived from donated human fat tissue — but it doesn’t contain living fat cells. Instead, it provides a scaffold of collagen, proteins, and extracellular matrix. After injection, the idea is that the body’s own fat cells migrate into that scaffold over several months. Allure +2 RealSelf.com +2 Lanluma is a poly-L-lactic acid (PLLA) implant material intended to stimulate collagen production and help restore volume in depressed or volume-deficient areas. Lanluma +2 drleylaarvas.com +2 Because both are designed to restore volume gradually (rather than instantly like a traditional filler), they appeal to patients seeking a more “natural” effect — less like a prosthetic augmentation and more like your own tissue regaining fullness. Some clinicians have used Renuva (or similar matrix-type injectables) for small-volume corrections: smoothing implant rippling, refining irregularities, or subtle contour improvements — often after implant removal or reconstructive surgery. RealSelf.com +2 Allure +2 ⚠️ Why — at least for now — these injections are not a reliable solution for upper-pole fullness or breast augmentation Volume limitations: For most patients, filling the entire upper pole — or substantially increasing breast volume — would require a lot of product. For Renuva, that often becomes impractical or “cost prohibitive.” RealSelf.com +2 RealSelf.com +2 Slow, unpredictable results: Because Renuva relies on your body’s own fat to repopulate the injected matrix, results are gradual (taking several months) and variable — some patients respond well, others less so. RealSelf.com +2 spotlightgroup.agency +2 Regulatory and safety concerns: In the U.S., Lanluma is not FDA-approved for breast augmentation. doctormedica.co +1 Use of injectables in or around breast tissue is more complex than other areas (face, hands, buttocks) — the tissue composition, blood supply, and functional demands of the breast differ. Some experts caution against expecting filler-type results in the breasts. RealSelf.com +2 RealSelf.com +2 Given the lack of long-term, large-volume outcome data, many plastic surgeons remain skeptical of using Renuva or similar injectables as a substitute for implants or fat transfer. RealSelf.com +1 Best use cases are modest corrections, not “augmentation”: In medical literature and clinical practice, Renuva is more commonly used for small corrections — like smoothing irregularities or subtle volume support — not for creating significant upper-pole fullness or a “boosted” breast shape. Sarasota Facial Aesthetics +2 Eterna Cosmetic Surgery +2 Because of all the above, many experienced plastic surgeons advise that for true volume or lift, the most reliable options remain: Breast implants, or Fat transfer (autologous fat grafting) With proper technique (and if you are a good candidate), fat transfer often yields more predictable, natural, and lasting results compared with experimental injectables for volume.